British Cosmetic Dermatology Group Study on Imiquimod for Xeroderma Pigmentosum

    July 2015 in “ British Journal of Dermatology ”
    Image of study
    TLDR Imiquimod improved skin pigmentation in most patients with xeroderma pigmentosum and may prevent further skin cancer, but some treatments can have side effects.
    In a study by the British Cosmetic Dermatology Group from 2015, 5% Imiquimod (Aldara) was tested on 10 patients with xeroderma pigmentosum (XP) and showed that 8 patients had improvement in facial lentigines, with 1 achieving complete clearance. The treatment, which involved three doses per week or daily dosing for 4-6 weeks, also suggested that Imiquimod may prevent further photocarcinogenesis. Additionally, the document reported two cases of adverse reactions to dermatological treatments: one patient developed nail discoloration from topical 5-fluorouracil, and another experienced a granulomatous reaction to eyebrow tattooing. The latter was treated with topical corticosteroids and steroid injections, with better results from the topical treatment. The findings indicate the potential of Imiquimod in treating pigmentation issues and the need for awareness of possible side effects from dermatological treatments.
    Discuss this study in the Community →

    Related Community Posts Join

    0 / 0 results
    — no results

    Similar Research

    5 / 436 results
      Internal Medicine: Retrospective Review of 120 Patients Over a 10-Year Period

      research Internal Medicine: Retrospective Review of 120 Patients Over a 10-Year Period

      July 2003 in “Journal of Cutaneous Medicine and Surgery”
      Certain drugs can cause skin lupus, but stopping the drug usually helps. Vaccines work against smallpox, genital herpes, and a type of human papillomavirus. More frequent light therapy clears psoriasis faster. Certain treatments work for psoriasis and dermatitis. A specific cream effectively treats a type of skin cancer. Low iron levels aren't directly linked to chronic hair loss.
      Cancer

      research Cancer

      July 2003 in “Journal of Cutaneous Medicine and Surgery”
      Some medications can improve skin conditions, while lifestyle factors like smoking and drinking may worsen them; treatments like monoclonal antibodies and imiquimod cream show promise for certain skin diseases.
      Surgery And Laser

      research Surgery And Laser

      July 2003 in “Journal of Cutaneous Medicine and Surgery”
      Various skin conditions like cutaneous lupus erythematosus, psoriasis, and basal cell carcinoma can be effectively treated with antihypertensive agents, NB-UVB phototherapy, and imiquimod cream respectively. Vaccines are effective against genital herpes and HPV-16 infection. Early intervention is crucial for conditions like diabetic foot ulcers and neonatal herpes. Certain dyes can cause hand dermatitis, and there's a link between smoking/drinking and psoriasis in men. No direct link was found between low iron levels and chronic hair loss in women.